{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CareVid", "chemistry", "in silico", "in vitro", "reverse transcription"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34681233", "DateRevised": {"Year": "2021", "Month": "10", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "30"}], "Language": ["eng"], "ELocationID": ["1009", "10.3390/ph14101009"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "14", "Issue": "10", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "30"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "HIV-1 Reverse Transcriptase Inhibition by Major Compounds in a Kenyan Multi-Herbal Composition (CareVid\u2122): In Vitro and In Silico Contrast.", "Abstract": {"AbstractText": ["CareVid is a multi-herbal product used in southwest Kenya as an immune booster and health tonic and has been anecdotally described as improving the condition of HIV-positive patients. The product is made up of roots, barks and whole plant of 14 African medicinal plants: <i>Acacia nilotica</i> (L.) Willd. ex Delile (currently, <i>Vachelia nilotica</i> (L.) P.J.H Hurter & Mabb.), <i>Adenia gummifera</i> (Harv.) Harms, <i>Anthocleista grandiflora</i> Gilg, <i>Asparagus africanus</i> Lam., <i>Bersama abyssinica</i> Fresen., <i>Clematis hirsuta</i> Guill. & Perr., <i>Croton macrostachyus</i> Hochst. ex Delile, <i>Clutia robusta</i> Pax (accepted as <i>Clutia kilimandscharica</i> Engl.), <i>Dovyalis abyssinica</i> (A. Rich.) Warb, <i>Ekebergia capensis</i> Sparm., <i>Periploca linearifolia</i> Quart.-Dill. & A. Rich., <i>Plantago palmata</i> Hook.f., <i>Prunus africana</i> Hook.f. Kalkman and <i>Rhamnus prinoides</i> L'Her. The objective of this study was to determine the major chemical constituents of CareVid solvent extracts and screen them for in vitro and in silico activity against the HIV-1 reverse transcriptase enzyme. To achieve this, CareVid was separately extracted using CH<sub>2</sub>Cl<sub>2</sub>, MeOH, 80% EtOH in H<sub>2</sub>O, cold H<sub>2</sub>O, hot H<sub>2</sub>O and acidified H<sub>2</sub>O (pH 1.5-3.5). The extracts were analysed using HPLC-MS equipped with UV diode array detection. HIV-1 reverse transcriptase inhibition was performed in vitro and compared to in silico HIV-1 reverse transcriptase inhibition, with the latter carried out using MOE software, placing the docking on the hydrophobic pocket in the subdomain of p66, the NNRTI pocket. The MeOH and 80% EtOH extracts showed strong in vitro HIV-1 reverse transcriptase inhibition, with an EC<sub>50</sub> of 7 \u03bcg\u00b7mL<sup>-1</sup>. The major components were identified as sucrose, citric acid, ellagic acid, catechin 3-hexoside, epicatechin 3-hexoside, procyanidin B, hesperetin <i>O</i>-rutinoside, pellitorine, mangiferin, isomangiferin, 4-<i>O</i>-coumaroulquinic acid, ellagic acid, ellagic acid <i>O</i>-pentoside, crotepoxide, oleuropein, magnoflorine, tremulacin and an isomer of dammarane tetrol. Ellagic acid and procyanidin B inhibited the HIV-1 reverse transcription process at 15 and 3.2 \u00b5g/mL<sup>-1</sup>, respectively. Docking studies did not agree with in vitro results because the best scoring ligand was crotepoxide (\u0394G = -8.55 kcal/mol), followed by magnoflorine (\u0394G = -8.39 kcal/mol). This study showed that CareVid has contrasting in vitro and in silico activity against HIV-1 reverse transcriptase. However, the strongest in vitro inhibitors were ellagic acid and procyanidin B."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sigowet-Soin Sub-County Hospital, Sondu-Kapsoit Road, Sigowet, Kericho County, P.O. Box 112, Kericho 20200, Kenya."}], "LastName": "Rotich", "ForeName": "Winnie", "Initials": "W"}, {"Identifier": ["0000-0001-7593-1289"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Royal Botanic Gardens, Kew, Kew Green, Richmond, Surrey TW9 3AE, UK."}], "LastName": "Sadgrove", "ForeName": "Nicholas J", "Initials": "NJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Royal Botanic Gardens, Kew, Kew Green, Richmond, Surrey TW9 3AE, UK."}], "LastName": "Mas-Claret", "ForeName": "Eduard", "Initials": "E"}, {"Identifier": ["0000-0002-8300-6891"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Royal Botanic Gardens, Kew, Kew Green, Richmond, Surrey TW9 3AE, UK."}], "LastName": "Padilla-Gonz\u00e1lez", "ForeName": "Guillermo F", "Initials": "GF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Pharmacognosy, School of Pharmacy, University of Nairobi, P.O. Box 19676-00202, Nairobi 00100, Kenya."}], "LastName": "Guantai", "ForeName": "Anastasia", "Initials": "A"}, {"Identifier": ["0000-0001-8079-7774"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Royal Botanic Gardens, Kew, Kew Green, Richmond, Surrey TW9 3AE, UK."}], "LastName": "Langat", "ForeName": "Moses K", "Initials": "MK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Khumalo G.P., Sadgrove N.J., Van Vuuren S.F., Van Wyk B.E. South Africa\u2032s Best BARK Medicines Prescribed at the Johannesburg Muthi Markets for Skin, Gut, and Lung Infections: MIC\u2019s and Brine Shrimp Lethality. Antibiotics. 2021;10:681. doi: 10.3390/antibiotics10060681.", "ArticleIdList": ["10.3390/antibiotics10060681", "PMC8227155", "34200286"]}, {"Citation": "Haacker M., Birungi C. Poverty as a barrier to antiretroviral therapy access for people living with HIV/AIDS in Kenya. Afr. J. AIDS Res. 2018;17:145\u2013152. doi: 10.2989/16085906.2018.1475401.", "ArticleIdList": ["10.2989/16085906.2018.1475401", "30003850"]}, {"Citation": "UNAIDS  Fact Sheet\u2014Latest Global and Regional Statistics on the Status of the AIDS Epidemic.  [(accessed on 22 August 2021)].  Available online:  https://www.unaids.org/en/resources/documents/2021/UNAIDS_FactSheet."}, {"Citation": "Rege A., Dahake R., Roy S., Chowdhary A. Screening of Natural Products for Anti-HIV Potential: An In vitro Approach. JOJ Immuno Virol. 2015;1:555556. doi: 10.19080/JOJIV.2016.01.555556.", "ArticleIdList": ["10.19080/JOJIV.2016.01.555556"]}, {"Citation": "Cherutich P., Kim A.A., Kellogg T.A., Sherr K., Waruru A., De Cock K.M., Rutherford G.W. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey. PLoS ONE. 2016;11:e0154318. doi: 10.1371/journal.pone.0154318.", "ArticleIdList": ["10.1371/journal.pone.0154318", "PMC4871583", "27192052"]}, {"Citation": "Lubinga S.J., Kintu A., Atuhaire J., Asiimwe S. Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: A cross-sectional analysis of magnitude and patterns of use, associated factors and impact on ART adherence. AIDS Care. 2012;24:1375\u20131383. doi: 10.1080/09540121.2011.648600.", "ArticleIdList": ["10.1080/09540121.2011.648600", "22292937"]}, {"Citation": "Mamba P., Adebayo S.A., Tshikalange T.E. Anti-microbial, anti-Inflammatory and HIV-1 reverse transcriptase activity of selected South African plants used to treat sexually transmitted diseases. Int. J. Pharmacogn. Phytochem. Res. 2016;8:1870\u20131876."}, {"Citation": "Namuddu B., Kalyango J.N., Karamagi C., Mudiope P., Sumba S., Kalende H., Wobudeya E., Kigozi B.K., Waako P. Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health. 2011;11:855. doi: 10.1186/1471-2458-11-855.", "ArticleIdList": ["10.1186/1471-2458-11-855", "PMC3270112", "22074367"]}, {"Citation": "Nlooto M., Naidoo P. Clinical relevance and use of traditional, complementary and alternative medicines for the management of HIV infection in local African communities, 1989\u20132014: A review of selected literature. PULA Botsw. J. Afr. Stud. 2014;28:105\u2013116."}, {"Citation": "Mushiwokufa W. Treating HIV Infection with Herbal Medicine: A Case Report. J. Tradit. Med. Clin. Naturop. 2016;5:1000192. doi: 10.4172/2573-4555.1000192.", "ArticleIdList": ["10.4172/2573-4555.1000192"]}, {"Citation": "Onifade A.A., Jewell A.P., Ajadi T.A., Rahamon S.K., Ogunrin O.O. Effectiveness of a herbal remedy in six HIV patients in Nigeria. J. Herb. Med. 2013;3:99\u2013103. doi: 10.1016/j.hermed.2013.04.006.", "ArticleIdList": ["10.1016/j.hermed.2013.04.006"]}, {"Citation": "Ndhlala A.R., Stafford G.I., Finnie J.F., van Staden J. Commercial herbal preparations in KwaZulu-Natal, South Africa: The urban face of traditional medicine. S. Afr. J. Bot. 2011;77:830\u2013843. doi: 10.1016/j.sajb.2011.09.002.", "ArticleIdList": ["10.1016/j.sajb.2011.09.002"]}, {"Citation": "Chepkwony P.C., Medina M., Medina M. Compounds and Compositions for Treating Infection. 20120190734A1. 2014 January 26;"}, {"Citation": "Medina M., Chepkwony P.C., Medina M. Medicinal and Herbal Composition and Uses Thereof. 8404284B2. U.S. Patent. 2010 December 23;"}, {"Citation": "Kloos H., Mariam D.H., Kaba M., Tadele G. Traditional medicine and HIV/AIDS in Ethiopia: Herbal medicine and faith healing: A review. Ethiop. J. Health Dev. 2013;27:141\u2013155."}, {"Citation": "Chinsembu K.C. Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants. Braz. J. Pharm. 2019;29:504\u2013528. doi: 10.1016/j.bjp.2018.10.006.", "ArticleIdList": ["10.1016/j.bjp.2018.10.006"]}, {"Citation": "Ahn M.J., Yoon K.D., Min S.Y., Lee J.S., Kim J.H., Kim T.G., Kim S.H., Kim N.G., Huh H., Kim J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol. Pharm. Bull. 2004;27:544\u2013547. doi: 10.1248/bpb.27.544.", "ArticleIdList": ["10.1248/bpb.27.544", "15056863"]}, {"Citation": "Figiel M., Krepl M., Park S., Poznanski J., Skowronek K., Golab A., Ha T., Sponer J., Nowotny M. Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase. J. Biol. Chem. 2018;293:191\u2013202. doi: 10.1074/jbc.M117.798256.", "ArticleIdList": ["10.1074/jbc.M117.798256", "PMC5766924", "29122886"]}, {"Citation": "Sluis-Cremer N. Future of nonnucleoside reverse transcriptase inhibitors. Proc. Natl. Acad. Sci. USA. 2018;115:637\u2013638. doi: 10.1073/pnas.1720975115.", "ArticleIdList": ["10.1073/pnas.1720975115", "PMC5789963", "29326232"]}, {"Citation": "Poongavanam V., Namasivayam V., Vanangamudi M., Shamaileh H.A., Veedu R.N., Kihlberg J., Murugan N.A. Integrative approaches in HIV-1 non-nucleoside reverse transcriptase inhibitor design. WIREs Comput. Mol. Sci. 2017;8:e1328. doi: 10.1002/wcms.1328.", "ArticleIdList": ["10.1002/wcms.1328"]}, {"Citation": "Tian L., Kim M.S., Li H., Wang J., Yang W. Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid. Proc. Natl. Acad. Sci. USA. 2018;115:507\u2013512. doi: 10.1073/pnas.1719746115.", "ArticleIdList": ["10.1073/pnas.1719746115", "PMC5777007", "29295939"]}, {"Citation": "Wei S.D., Zhou H.C., Lin Y.M. Antioxidant activities of fractions of polymeric procyanidins from stem bark of Acacia confusa. Int. J. Mol. Sci. 2011;12:1146\u20131160. doi: 10.3390/ijms12021146.", "ArticleIdList": ["10.3390/ijms12021146", "PMC3083696", "21541049"]}, {"Citation": "Al-Nour M.Y., Ibrahim M.M., Elsaman T. Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug with Multiple Mechanisms of Action. Curr. Pharmacol. Rep. 2019;5:255\u2013280. doi: 10.1007/s40495-019-00181-w.", "ArticleIdList": ["10.1007/s40495-019-00181-w", "PMC7100491", "32226726"]}, {"Citation": "Sharma B., Yadav A., Dabur R. Interactions of a medicinal climber Tinospora cordifolia with supportive interspecific plants trigger the modulation in its secondary metabolic profiles. Sci. Rep. 2019;9:14327. doi: 10.1038/s41598-019-50801-0.", "ArticleIdList": ["10.1038/s41598-019-50801-0", "PMC6778175", "31586109"]}, {"Citation": "Tane P., Tatsimo S., Conolly J.D. Crotomacrine, a new clerodane diterpene from the fruits of Croton macrostachyus. Tetrahedron Lett. 2004;45:6997\u20136998. doi: 10.1016/j.tetlet.2004.08.001.", "ArticleIdList": ["10.1016/j.tetlet.2004.08.001"]}, {"Citation": "Rasmussen B., Nkurunziza A.-J., Witt M., Oketch-Rabah H.A., Jaroszewski J.W., Staerk D. Dovyalicin-type spermidine alkaloids from Dovyalis species. J. Nat. Prod. 2006;69:1300\u20131304. doi: 10.1021/np060204e.", "ArticleIdList": ["10.1021/np060204e", "16989523"]}, {"Citation": "Sinan K.I., Chiavaroli A., Orlando G., Bene K., Zengin G., Cziaky Z., Jeko J., Mahomoodally M.F., Picot-Allain M.C.N., Menghini L., et al. Biopotential of Bersama abyssinica Fresen Stem Bark Extracts: UHPLC Profiles, Antioxidant, Enzyme Inhibitory, and Antiproliferative Propensities. Antioxidants. 2020;9:163. doi: 10.3390/antiox9020163.", "ArticleIdList": ["10.3390/antiox9020163", "PMC7094211", "32079363"]}, {"Citation": "Smerdon S.J., Jager J., Wang J., Kohlstaedt L.A., Chirino A.J., Friedman J.M., Rice P.A., Steitz T.A. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 1994;91:3911\u20133915. doi: 10.1073/pnas.91.9.3911.", "ArticleIdList": ["10.1073/pnas.91.9.3911", "PMC43692", "7513427"]}, {"Citation": "Kohlstaedt L.A., Wang J., Friedman J.M., Rice P.A., Steitz T.A. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science. 1992;256:1783\u20131790. doi: 10.1126/science.1377403.", "ArticleIdList": ["10.1126/science.1377403", "1377403"]}, {"Citation": "Ren J., Nichols C., Bird L., Chamberlain P., Weaver K., Short S., Stuart D.I., Stammers D.K. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. J. Mol. Biol. 2001;312:795\u2013805. doi: 10.1006/jmbi.2001.4988.", "ArticleIdList": ["10.1006/jmbi.2001.4988", "11575933"]}, {"Citation": "Das K., Martinez S.E., Bauman J.D., Arnold E. HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism. Nat. Struct Mol. Biol. 2012;19:253\u2013259. doi: 10.1038/nsmb.2223.", "ArticleIdList": ["10.1038/nsmb.2223", "PMC3359132", "22266819"]}, {"Citation": "Hevener K.E., Zhao W., Ball D.M., Babaoglu K., Qi J., White S.W., Lee R.E. Validation of molecular docking programs for virtual screening against dihydropteroate synthase. J. Chem. Inf. Model. 2009;49:444\u2013460. doi: 10.1021/ci800293n.", "ArticleIdList": ["10.1021/ci800293n", "PMC2788795", "19434845"]}, {"Citation": "Rather L.J., Shahid-ul-Islam S., Mohammad F. A review of its traditional uses, phytochemistry, and pharmacology. Sustain. Chem. Pharm. 2015;2:12\u201330. doi: 10.1016/j.scp.2015.08.002.", "ArticleIdList": ["10.1016/j.scp.2015.08.002"]}, {"Citation": "Barbosa F., Hlashwayo D., Sevastyanov V., Chichava V., Mataveia A., Boane E., Cala A. Medicinal plants sold for treatment of bacterial and parasitic diseases in humans in Maputo city markets, Mozambique. BMC Complement. Med. Ther. 2020;20:19. doi: 10.1186/s12906-019-2809-9.", "ArticleIdList": ["10.1186/s12906-019-2809-9", "PMC7076832", "32020866"]}, {"Citation": "Chhabra S.C., Mahunnah R.L.A., Mshiu E.N. Plants used in traditional medicine in Eastern Tanzania. V. Angiosperms (Passifloraceae to Sapindaceae) J. Ethnopharmacol. 1991;33:143\u2013157. doi: 10.1016/0378-8741(91)90173-B.", "ArticleIdList": ["10.1016/0378-8741(91)90173-B", "1943163"]}, {"Citation": "Jeruto P., Lukhoba C., Ouma G., Otieno D., Mutai C. An ethnobotanical study of medicinal plants used by the Nandi people in Kenya. J. Ethnopharmacol. 2008;116:370\u2013376. doi: 10.1016/j.jep.2007.11.041.", "ArticleIdList": ["10.1016/j.jep.2007.11.041", "18215481"]}, {"Citation": "Kisangau D.P., Herrmann T.M., Lyaruu H.V., Hosea K.M., Joseph C.C., Mbwambo Z.H., Masimba P.J. Traditional knowledge, use practices and conservation of medicinal plants for HIV/AIDS care in rural Tanzania. Ethnobot. Res. Appl. 2011;9:043\u2013057. doi: 10.17348/era.9.0.43-57.", "ArticleIdList": ["10.17348/era.9.0.43-57"]}, {"Citation": "Kisangau D.P., Lyaruu H.V., Hosea K.M., Joseph C.C. Use of traditional medicines in the management of HIV/AIDS opportunistic infections in Tanzania: A case in the Bukoba rural district. J. Ethnobiol. Ethnomed. 2007;3:29. doi: 10.1186/1746-4269-3-29.", "ArticleIdList": ["10.1186/1746-4269-3-29", "PMC1941724", "17623081"]}, {"Citation": "Adongo O. Master\u2019s Thesis. Kenyatta University; Kahawa, Kenya: 2012. Medicinal Plants of Chuka Community in Tharaka Nithi County, Kenya and Some of Their Selected Essential Elements."}, {"Citation": "Madikizela B., Ndhlala A.R., Finnie J.F., Staden J.V. In vitro antimicrobial activity of extracts from plants used traditionally in South Africa to treat tuberculosis and related symptoms. Evid. Based Complementary Altern. Med. 2013;2013:840719. doi: 10.1155/2013/840719.", "ArticleIdList": ["10.1155/2013/840719", "PMC3603154", "23533527"]}, {"Citation": "Kidane B., van Andel T., van der Maesen L.J., Asfaw Z. Use and management of traditional medicinal plants by Maale and Ari ethnic communities in southern Ethiopia. J. Ethnobiol. Ethnomed. 2014;10:46. doi: 10.1186/1746-4269-10-46.", "ArticleIdList": ["10.1186/1746-4269-10-46", "PMC4055949", "24898079"]}, {"Citation": "Al-Taweel A.M., El-Deeb K.S., Abdel-Kader M.S., Mossa J.S. GC/MS Analysis of the Fatty Acids of Three Clematis species Growing in Saudi Arabia and their Anti-inflammatory activity. Saudi Pharm. J. 2007;15:224."}, {"Citation": "Watt J.M., Breyer-Brandwijk M.G. The Medicinal and Poisonous Plants of Southern and Eastern Africa. 2nd ed. Livingstone; London, UK: 1962."}, {"Citation": "Maroyi A. Ethnopharmacological Uses, Phytochemistry, and Pharmacological Properties of Croton macrostachyus Hochst. Ex Delile: A Comprehensive Review. Evid. Based Complementary Altern. Med. 2017;2017:1694671. doi: 10.1155/2017/1694671.", "ArticleIdList": ["10.1155/2017/1694671", "PMC5660826", "29234365"]}, {"Citation": "Schmelzer G.H., Gurib-Fakim A., Arroo R., Bosch C.H., de Ruijter A., Simmonds M.S.J., Lemmens R.H.M.J., Oyen L.P.A. Plant. Resource of Tropical Africa 11 (1) Medicinal Plants 1. Backhuys Publishers; Leiden, The Netherlands: 2008."}, {"Citation": "Chirchir K., Cheplogoi P., Omolo J., Langat M.K. Chemical constituents of Solanum mauense (Solanaceae) and Dovyalis abyssinica (Salicaceae) Int. J. Biol. Chem. Sci. 2018;12:999\u20131007. doi: 10.4314/ijbcs.v12i2.29.", "ArticleIdList": ["10.4314/ijbcs.v12i2.29"]}, {"Citation": "Omwoyo H.N., Maingi J., Kebira A. The efficacy of some medicinal plants used locally within Transmara west, Narok County, Kenya against selected Enterobacteria and Candida. IOSR J. Pharm. Biol. Sci. 2017;12:115\u2013122. doi: 10.9790/3008-120101115122.", "ArticleIdList": ["10.9790/3008-120101115122"]}, {"Citation": "Mulaudzi R., Ndhlala A., Kulkarni M., Finnie J., Van Staden J. Anti-inflammatory and mutagenic evaluation of medicinal plants used by Venda people against venereal and related diseases. S. Afr. J. Bot. 2013;146:173\u2013179. doi: 10.1016/j.sajb.2013.02.037.", "ArticleIdList": ["10.1016/j.sajb.2013.02.037", "23276783"]}, {"Citation": "Tuasha N., Petros B., Asfaw Z. Medicinal plants used by traditional healers to treat malignancies and other human ailments in Dalle District, Sidama Zone, Ethiopia. J. Ethnobiol. Ethnomed. 2018;14:1\u201322. doi: 10.1186/s13002-018-0213-z.", "ArticleIdList": ["10.1186/s13002-018-0213-z", "PMC5813379", "29444684"]}, {"Citation": "Jeruto P., Too E., Mwamburi L., Amuka O. An Inventory of Medicinal Plants used to Treat Gynaecological-Obstetric-Urino-Genital Disorders in South Nandi Sub County in Kenya. J. Nat. Sci. Res. 2015;5:136\u2013152."}, {"Citation": "Bii C.C., Korir K., Rugutt J., Mutai C. The potential use of Prunus africana for the control, treatment and management of common fungal and bacterial infections. J. Med. Plants Res. 2010;4:995\u2013998. doi: 10.5897/JMPR09.227.", "ArticleIdList": ["10.5897/JMPR09.227"]}, {"Citation": "Komakech R., Kang Y., Lee J.H., Omujal F. A Review of the Potential of Phytochemicals from Prunus africana (Hook f.) Kalkman Stem Bark for Chemoprevention and Chemotherapy of Prostate Cancer. Evid. Based Complementary Altern. Med. 2017;2017:3014019. doi: 10.1155/2017/3014019.", "ArticleIdList": ["10.1155/2017/3014019", "PMC5327751", "28286531"]}, {"Citation": "Dzoyem J.P., Eloff J.N. Anti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South Africa. J. Ethnopharmacol. 2015;160:194\u2013201. doi: 10.1016/j.jep.2014.11.034.", "ArticleIdList": ["10.1016/j.jep.2014.11.034", "25476488"]}, {"Citation": "Kiringe J.W. A survey of traditional health remedies used by the Maasai of Southern Kajiado District, Kenya. Ethnobot. Res. Appl. 2006;4:61\u201374. doi: 10.17348/era.4.0.61-74.", "ArticleIdList": ["10.17348/era.4.0.61-74"]}, {"Citation": "Tabuti J.R., Kukunda C.B., Waako P.J. Medicinal plants used by traditional medicine practitioners in the treatment of tuberculosis and related ailments in Uganda. J. Ethnopharmacol. 2010;127:130\u2013136. doi: 10.1016/j.jep.2009.09.035.", "ArticleIdList": ["10.1016/j.jep.2009.09.035", "19799983"]}, {"Citation": "Sadgrove N.J., Jones G.L. From Petri Dish to Patient: Bioavailability Estimation and Mechanism of Action for Antimicrobial and Immunomodulatory Natural Products. Front. Microbiol. 2019;10:2470. doi: 10.3389/fmicb.2019.02470.", "ArticleIdList": ["10.3389/fmicb.2019.02470", "PMC6834656", "31736910"]}, {"Citation": "Serra A., Macia A., Romero M.P., Valls J., Blade C., Arola L., Motilva M.J. Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models. Br. J. Nutr. 2010;103:944\u2013952. doi: 10.1017/S0007114509992741.", "ArticleIdList": ["10.1017/S0007114509992741", "20003617"]}, {"Citation": "Gonz\u00e1lez-Sarr\u00edasa A., Garc\u00eda-Villalba R., N\u00fa\u00f1ez-S\u00e1nchez M.A., Tom\u00e9-Carneiroa J., Zafrilla P., Mulero J., Tom\u00e1s-Barber\u00e1naJuan F.A., Esp\u00edn C. Identifying the limits for ellagic acid bioavailability: A crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J. Funct. Foods. 2015;19:225\u2013235. doi: 10.1016/j.jff.2015.09.019.", "ArticleIdList": ["10.1016/j.jff.2015.09.019"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "25"}, {"Year": "2021", "Month": "9", "Day": "22"}, {"Year": "2021", "Month": "9", "Day": "28"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "1", "Minute": "6"}, {"Year": "2021", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["34681233", "PMC8541497", "10.3390/ph14101009", "ph14101009"]}}], "PubmedBookArticle": []}